Elite Pharmaceuticals Inc (ELTP)

[Cognition]

Pieces of the puzzle taken from an article by leonardzehr
08/06/2013
Mr. Treppel recalls that Elite previously tried to license the once-a-day formulation in the European market and had found a partner. “At that time, we didn’t have the financial wherewithal to pursue that opportunity. It’s fair to say that that opportunity may get looked at again because there are opportunities overseas, especially the European and Asian markets for opioids.”

03/30/14
I guess Canada now too!
Who did they just hire?
After the vote to increase the AS you think they'll have the financial wherewithal to pursue those opportunities?
My vote is yes.

Here's more from the same August 2013 article.

The goal of the clinical program would be to show that Elite’s formulation is bioequivalent to Purdue Pharma’s twice-daily OxyContin, which has annual sales approaching $3-billion. “This would be a pivotal point for the company because once you complete a successful bioequivalency study, you are well on your way to having a commercial product,”

03/30/14
Now I don't know if the ELI-200 bioequivalence study used Perdue's product as a comparison but I do know Elite had successful results.
And those successful results mean they are well on their way to having a commercial product. Very likely an international one at that!

I only get one post a day. Sorry I can't respond.